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Cells are able to sense their physical surroundings through mechanotransduction.  
In doing so, they can translate the mechanical forces and deformations into a wide range 
of biochemical signals and genetic programs which can adjust their structure and 
extracellular environment.  The urinary bladder is a physically active organ that 
undergoes periodic stretching as part of its normal function.  In the bladder, abnormal 
pressure from a variety of pathologic conditions can result in forces which, over time, can 
alter the genetic expression of the proteins of the extracellular matrix.  To determine the 
role that stretching or mechanical deformation may play in altering the synthetic 
phenotype of bladder wall cells, a series of experiments were carried out to quantify 
several extracellular matrix messenger ribonucleic acids (mRNAs) and their 
corresponding protein levels after mechanical challenge.  This report first summarizes the 
current knowledge about regulation of cell function by mechanical forces and then 
presents data on the effect(s) of mechanical force on several mechanosensitive genes 
expressed by human bladder smooth muscle cells (BSMCs).   
Using this experimental system, we demonstrated that BSMCs were acutely 
sensitive to mechanical deformation and showed alteration of many structural and 
extracellular matrix genes.   This study demonstrates that BSMC extracellular matrix 
secretory phenotype can be altered by the mechanical deformation experienced by these 
cells.  These data support the concept that deformation of the bladder wall affects the 
secretory phenotype of BSMCs and can result in an altered extracellular matrix 
composition.     
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1. INTRODUCTION:  
The purpose of this project is to define, at the molecular level, the process by 
which gene expression of the extracellular matrix is regulated by mechanical forces in the 
Human Bladder Smooth Muscle cells (BSMCs).  The goal is to first localize several 
functionally distinct transmembrane proteins; Sarcoglycans (α, β, γ, δ and ε), cytoskeletal 
proteins Vimentin, and Desmin to verify their presence in the cultured BSMCs using 
fluorescent-labeled antibodies specific for each protein.  The sarcoglycans are primarily 
responsible for transferring intracellular force generated by the interaction of actin and 
myosin while the extracellular proteins are responsible for linking the cells to the 
extracellular matrix. These proteins comprise several collagen matrix proteins, e.g., type 
I, type III and type IV collagens and an integrin-receptor (11, 64).  To evaluate the 
functions of these proteins, we will subject the BSMCs, using a cell strain apparatus, to a 
level of force which mimics those experienced by the bladder wall during the 
filling/emptying cycles.  This investigation seeks to find supporting evidence to 
determine if altered mechanical stimulation of bladder smooth muscle cells results in an 
up-regulation of type III collagen as well as additional genes which mediate the transfer 
of intracellular force to the extracellular environment.   
 
1.1 Significance:  
The hardening or stiffening seen in diseased tissue is typically associated with an 
overproduction of the abundant matrix protein collagen (11) which is the most abundant 
protein in the body (24).  A challenge to current research is to elucidate the biochemical 
steps that initiate an over-accumulation of collagen and associated proteins of the 
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extracellular matrix.  It is plausible that drugs and other interventions could be used to 
stop or slow the process and remove or dramatically decrease the deleterious effects of 
the excess matrix that mediate fibrotic disease.  Since the collagen genes can be regulated 
and influenced by force (7), it is likely that specific steps in the control process can be 
targeted either by drugs or other interventions to retard its accumulation (40).  Therefore, 
the ideal effect of such research would be to define the mechanism by which proteins of 
the extracellular matrix are up-regulated causing an overproduction of collagen.     
Diseases such as pulmonary, liver, kidney, and bladder fibrosis, systemic sclerosis 
and urethral strictures are characterized by the accumulation of excess collagen and other 
connective tissue structural macromolecules (5).  Specifically, in the bladder wall, the 
additional connective tissue can interfere with the normal physiologic operating pressures 
of the bladder which, in turn, can be transmitted in a retrograde fashion to the kidneys, 
ultimately compromising their function and leading to kidney failure (30).  Numerous 
studies have documented changes in connective tissue associated with bladder 
dysfunction and pathology (2, 30, 63); however, the mechanism by which these changes 
are initiated at the cell and molecular levels is currently unknown.   
 
1.2 Background: 
Fibrosis, the excessive and persistent formation of scar tissue, is responsible for 
morbidity and mortality associated with organ failure in a variety of chronic diseases 
affecting the lung, kidney, eyes, heart, liver, bladder, and skin.  Fibroproliferative 
diseases, including chronic pulmonary, hepatic, renal, vascular, and bladder fibrosis, 
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contribute to nearly half of all deaths in 2002 in the USA (34).  These disorders 
frequently affect multiple organ systems, complicating the elucidation of their underlying 
pathogenesis and hindering development of effective treatments.   
Many cells and tissues exist in an active mechanical environment and experience 
tensional, compressional, pressure-induced, and shearing deformations (61).  For 
example, lung tissue is stretched during inspiration.  Endothelial cells lining the blood 
vessels within the body experience shearing deformations owing to the blood flow 
against their luminal surfaces (44).  The bladder, under normal circumstances, fills with 
little or no increase in pressure.  When the volume capacity is reached, afferent signals 
from stretch receptors trigger the micturition reflex (67).  The bladder then empties and a 
new filling process begins.  In order to accomplish this function, the wall of the bladder 
must have mechanical properties which permit it to sustain major volume changes and 
strains without showing signs of irreversible changes.  Although the type, duration, 
intensity, and frequency of these forces may be different at various anatomical sites 
throughout the body, cells likely perceive these forces in a similar fashion and convert 
them into biochemical signals which alter cell behavior.  In the bladder, it is likely that 
the mechanical forces regulate cells by activating/deactivating different sets of genes (4). 
The process by which a cell is subjected to mechanical force and converts that 
force into a biochemical responses is termed mechanotransduction (9).  This process is 
poorly understood owing to the difficultly in reconstructing force environments to which 
cells are normally exposed in vivo; however, it is likely that cells operate optimally 
within a range of equilibrium force parameters.  If this range were to be exaggerated or 
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exceeded, the cell phenotype could change and have pathological consequences resulting 
in hypertension, hyperplasia, altered secretion of proteins in an autocrine and/or paracrine 
fashion and differential responses to external stimuli and cytokines (43).  Compliance (Δ 
volume/ Δ pressure), a measure of bladder storage function, has been shown to change in 
disease states and during fetal development (32).  During fetal development, there is 
evidence of active remodeling of the bladder wall (43).  Biochemical measurements of 
type I and type III collagens show quantitative changes which accompany physiological 
changes (58).   
Urine storage problems arise when the bladder fails to remain relaxed when filling 
causing the bladder to operate at increased pressures which can be transmitted to the 
kidneys causing damage and ultimately kidney failure.  Abnormal bladder pressure can 
be the result of neurogenic factors secondary to stroke, Parkinson’s disease, multiple 
sclerosis, or spinal cord injury (28, 46, 53).  Physical blockage of the bladder outlet 
(obstruction or BPH) can cause the same pressure-related problems.  The aging process is 
associated with intermittent increases in bladder pressure which can result in involuntary, 
non-voiding contractions (bladder overactivity).  Regardless of the source of a particular 
pathology, when the cellular components of the bladder are subjected to irregular cycles 
of filling and emptying, and/or if the velocity (strain rate) at which forces are applied to 
the bladder wall is altered as a consequence of overactivity, changes in collagen gene 
expression can occur (22). 
Collagens are the major structural protein of the body which are encoded by a 
family of over 30 genes and which are responsible for its synthesis.  These genes respond 
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to a variety of signals from both inside and outside the cell (63).  Compliance changes 
that occur as a consequence of the overproduction of collagen are the fundamental 
problem behind fibrotic disorders such as pulmonary fibrosis, cirrhosis, and scleroderma 
(14).  A thorough understanding of the role of forces in these pathologies and the 
biochemical mechanism underlying gene expression will guide treatment and other 
therapies to inhibit these diseases. 
Based upon prior work and new preliminary data, it has been demonstrated that 
collagen gene expression can be manipulated by applying different modes of mechanical 
force to cells (3, 10).  This information can be used to implement therapies whose goal is 
to ameliorate the deleterious effects caused by overproduction of collagen, i.e., 
structurally similar drugs such as mithramycin, mitoxantrone, daunorubicin, and 
bisanthracycline, which mimic and interfere with transcription factors binding to their 
cognate DNA elements thus preventing their activation (3).  If such therapies can be 
further refined, they offer novel ways of preventing the harmful effects of excessive 
collagen deposition on the normal physiologic functions of tissues and organs.  Since 
these drugs rely on their molecular structures to mimic the actual transcription factor, 
they can only be identified through an understanding of the molecular process by which 
gene activation occurs.     
 
1.3 Proposal: 
We will test our hypothesis that mechanical stimulation BSMCs results in 
increased expression of extracellular matrix genes and genes which mediate force transfer 
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intracellularly in BSMCs.  Specifically, we will study changes in the expression of 15 
genes whose encoded proteins are subdivided into 3 groups:  1); Matrix and matrix 
modulatory proteins, 2); Sarcolemma-associated proteins which mediate force transfer, 
and 3); Cytoskeletal genes which link sarcolemma associated proteins with actin and 
myosin intracellularly.  [Expression levels of type III collagen (COL3A1), Connective 
Tissue Growth Factor (CTGF), Integrin β-1 (ITGB1), MMP1 and TIMP1 genes were 
quantified].  
 
Matrix and Matrix Modulatory Genes 
Collagen, the major structural component of the bladder wall, is a family of 
proteins which make up approximately 30% of the dry weight of human tissue (1).  There 
are 26+ different types of collagen with approximately 30+ unique genes, each of which 
codes for a specific collagen peptide.  The most abundant collagen found in connective 
tissue is type I collagen which is a heterotrimetric molecule composed of two α-1 
polypeptides [ 1(IV)] and one α-2 polypeptide [ 2(IV)], each of which is the product of 
an individual gene; COL1A1 and COL1A2, respectively (48).  The polypeptides products 
encoded by these unique genes associate with one another to form a rod-like triple helical 
molecule that has high tensile strength, is relatively inelastic, and is a major contributor to 
the overall mechanical properties of tissues and organs. (16). 
Type III collagen is a fibrillar collagen and serves as a major structural 
component of the bladder wall.  Type III collagen is often associated with type I collagen.  
Previous experiments have shown that either type III collagen is minimally regulated 
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during development or that there is a highly sensitive post-transcriptional response (8, 
50).  This suggests that there may be an additional control mechanism which regulates 
the levels of type III collagen in the bladder wall.  Since previous studies have 
demonstrated that type III collagen changes during development and in pathologic states 
(50), it is plausible that even small fluctuations in mRNA expression could alter the rate 
of synthesis of type III collagen and ultimately influence the collagen fiber composition 
of the bladder wall.  Changes at the protein level are generally preceded by alterations in 
the gene activity of the respective genes that encode for these proteins.  Previous studies 
have demonstrated that alterations in type III collagen is associated with changes in the 
compliance properties of the bladder wall.  Thus structural fibers containing type III 
collagen play a significant role in tissue stiffening.  However, the exact mechanism by 
which type III collagen gene expression is up-regulated in unknown.  
Collagens play a unique structural role in association with other unique elements 
of the bladder wall.  Without the appropriate connections between the muscle cells and 
other components of the bladder wall extracellular matrix, the ability of the bladder to 
empty would be severely compromised.  In normal bladders, the composition is 
approximately 25% type III collagen and 75% type I collagen (1).  In bladders with 
progressive fibrotic changes, this ratio shifts to approximately 33% type III collagen and 
66% type I collagen (1).  Previous experiments support the idea that abnormal cycling 
results in progressive fibrosis of the bladder (50).  This fibrosis is characterized by 
infiltration of some detrusor muscle bundles with increased quantities of type III 
collagen. 
8 
CTGF is a matrix-associated protein which, similar to transforming growth factor 
beta (TGF-β), can stimulate extracellular matrix production.  CTGF also plays a vital role 
in extracellular matrix remodeling and wound healing.  It is widely accepted that CTGF 
promotes the development of fibrosis in collaboration with transforming growth factor 
TGF-β (36).  As well, it has been implicated in extracellular matrix remodeling, wound 
healing, scleroderma, and other fibrotic processes since it is capable of upregulating both 
matrix metalloproteases (MMPs) and their inhibitors (TIMPs).  Thus, CTGF has the 
potential to activate both the synthesis and degradation of the extracellular matrix.   
CTGF and TGF-β are ubiquitous mediators of fibrogenesis, although the precise 
mechanisms that underlie their concerted effect remain unclear (25).  Because TGF-β is a 
potent inducer of CTGF, most models postulate that CTGF acts as a downstream 
mediator of TGF- β activity, whereas other studies support an independent, rather than 
sequential, relationship between the two (20).     
CTGF is a multifunctional, cysteine-rich, matrix-associated, heparin binding 
protein that is normally expressed at low levels but dramatically enriched in virtually all 
fibrotic conditions.  In vitro, CTGF mirrors some of the effects of TGF- β on skin 
fibroblasts, such as stimulation of extracellular matrix production, chemotaxis, 
proliferation, and integrin expression (20).  It also regulates multiple processes that 
contribute to fibrogenesis, including cell proliferation, migration, adhesion, survival, and 
extracellular matrix production.   
 When an anti-CTGF antibody (FG-3019) is introduced into a system, there is 
consistent reduction in the fibrotic response.  Thus, the anti-fibrotic activity of the 
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antibody, FG-3019, in this model supports a key role for CTGF in mediating fibrogenesis 
(41).        
Integrins are a large family of membrane receptors, consisting of α-, and β-
subunits, which together produce twenty-four distinct heterodimers, and play a pivotal 
role in the interaction of cells with the extracellular matrix (29, 42).  Integrins serve as the 
bridge between the extracellular matrix, the intracellular signaling machinery, and the 
actin cytoskeleton.  Such interaction regulates the organization of cells in organs and 
tissues during development as well as cell differentiation and proliferation (15).   
Cells govern tissue shape by exerting highly regulated forces at sites of matrix 
adhesion, which is the integrin receptor.  Cells shape tissue by pulling on neighboring 
cells and extracellular matrices, creating specific levels of tension.  In turn, cells are 
finely attuned to the forces and rigidity of their surroundings.  As rigidity is defined by 
the force per unit displacement, rigidity-sensing cells must measure both force and 
displacement.  As the major force-bearing adhesion-receptor protein, integrins have a 
central role in how cells sense and respond to the mechanics of their surroundings (18).  
Recent studies have shown that a key aspect of mechanotransduction is the cycle by 
which integrins bind to the matrix at the leading cell edge, attach to the cytoskeleton, 
transmit mechanical force, aggregate in the plasma membrane as part of increasingly 
strengthened adhesion complexes, unbind and, ultimately, are recycled (17).  Within this 
mechanical cycle, integrins themselves exhibit intramolecular conformational change that 
regulates their binding affinity and may also be dependent upon force. 
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The integrin mechanical cycle is crucial for cellular function and depends upon 
biophysical and biochemical changes in integrin structure post-translational modifications 
of integrins and associated proteins.  Force likely accelerates integrin activation, both by 
extracellular and intracellular rearrangements, induces protein recruitment through 
protein stretching, and accelerates integrin clustering leading to deactivation.  Dispersal 
of adhesion contacts is favored by the loss of tension.   
Finally, we will analyze the gene expression of Matrix Metalloproteinase-1 
(MMP-1) and Tissue Inhibitor of Metalloproteinases-1 (TIMP-1).  These matrix-
associated proteins are involved in the breakdown of the extracellular matrix.   
Matrix Metalloprotease-1, or MMP-1, is an interstitial collagen protease in 
humans which plays a fundamental role in the re-modeling of the extracellular matrix, 
specifically type I, type II, and type III collagen (47).  In normal physiologic processes, 
such as embryonic development, tissue remodeling, and reproduction, matrix 
metalloproteases (MMPs) are responsible for the breakdown of the extracellular matrix.  
MMPs are a family of twenty-four genes which are organized into six different groups 
based on their domain organization and substrate preference (52).  These zinc-dependent 
endopeptidases also breakdown the extracellular matrix in disease states such as arthritis 
and metastasis (52).  They are responsible for the degradation of a wide range of 
extracellular components and a small number of bioactive molecules, including laminin, 
fibronectin, vitronectin, elastin, and proteoglycans (47, 52).   
The basic structure of the active form of MMP-1 contains an single peptide which 
directs MMP-1 to the secretory or plasma membrane, a domain that maintains 
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inactivation of the enzyme by occupying the active site, a zinc-containing catalytic 
domain, and a hinge region which links the catalytic domain to the hemopexin-like 
domain which mediated interaction with substrates and confers specificity of the enzymes 
(52).  Activation of MMP-1 following secretion from cells depends on disruption of the 
prodomain region with the catalytic site, which may occur by conformation changes of 
proteolytic removal of the prodomain (6).   
In vivo activity of MMP-1 is highly regulated.  It is generally expressed at very 
low levels and its transcription is tightly controlled either positively or negatively by 
cytokines and growth factors (6).  MMP-1 is first secreted as an inactive preprotein and 
activated only after a portion is cleaved by extracellular proteinases (38).  MMP-1’s 
activity is highly regulated by an endogenous inhibitor: Tissue Inhibitor of 
Metalloproteinase-1 (TIMP-1) (38).  MMP genes with dysfunctional, or absent, 
regulation have been implicated in many diseases including arthritis, chronic ulcers, and 
cancer (52). 
The breakdown of the extracellular matrix is systematic and highly regulated by 
tissue inhibitor of matrix metalloprotease (TIMP) activity (52).  Four members of the 
TIMP family have been characterized, designated as TIMP-1, TIMP-2, TIMP-3, and 
TIMP-4.  TIMP-1 is a natural inhibitor of matrix metalloprotease-1 (MMP-1), 
maintaining the balance between extracellular matrix deposition and degradation in 
different physiological processes (21).  In addition to its role as an inhibitor of MMP-1, 
TIMP-1 is able to promote cell proliferation in a wide range of cell types, and may also 
have anti-apoptotic functions and anti- and pro-angiogenc functions (1, 33).   
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Normally, TIMP-1 concentrations far exceed the concentration of MMP-1 in 
tissue and extracellular fluids.  A disturbed balance has been identified in several 
pathologic conditions, such as cancer, rheumatoid arthritis, and periodontitis.  
Accelerated growth of the extracellular matrix occurs in various pathologic processes, 
including inflammation, chronic degenerative diseases, and some tumors (33, 57).  In 
these cases, TIMP-1 can slow the progression of disease and/or inhibit time growth, 
invasion, and metastasis due to their MMP-1 inhibitory activity (65).  Thus, transcription 
of the TIMP-1 gene is highly regulated and inducible by cytokines and hormones, as well 
growth factors that influence MMP-1 expression, i.e., TGF-β and interleukins.  In its 
soluble form, TIMP-1 is preferentially expressed in epithelial tissue, cartilage, and 
muscle (52).  The formation of the TIMP-prometalloproteinase complex modulates the 
activation of the enzyme.           
During mechanical stimulation of the cell, wherein the collagen production is up-
regulated, we expect to see this collagenase down-regulated.  Similarly, TIMP-1 is an 
irreversible inactivator of metalloproteinases; specifically MMP-1.  If MMP-1 presence 
were to decline in the extracellular matrix, we believe the homeostatic process of the cell 
would also decrease the relative levels of TIMP-1 through a negative-feedback system.    
 
Sarcolemma-Associated Proteins Which Mediate Force Transfer 
The Sarcoglycans (α, β, γ, δ, ε and ζ) are a family of N-glycosylated 
transmembrane proteins characterized by a short intra-cellular domain, a single 
transmembrane domain, and a large extracellular domain (54).  These proteins form a 
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complex, the sarcoglycan complex (SGC), which, with other proteins, stabilizes the 
muscle cell membrane and mediates transfer of force generated intracellularly to 
extracellular matrix components.  The SGC is a component of the Dystrophin 
Glycoprotein Complex (DGC).  A diagram of this complex is shown in Figure 1, and 
comprises dystrophin, dystroglycan and the sarcoglycan complex.  The DGC is a 
membrane-spanning complex that physically links the interior cytoskeleton to the 
extracellular matrix in muscle (51).  While dystroglycan is found in nearly all cell types, 
the sarcoglycan complex is exclusively found in muscle cells.   
 
Figure 1: The dystrophin glycoprotein complex is a 
membrane-spanning complex that links the interior 
cytoskeleton to the extracellular matrix in muscle cells.  
It is critical for muscle integrity.  The DGC is composed 
of Dystrophin, an elongated cytoskeletal protein that 
links to the cytoplasmic γ-actin and the transmembrane 
components of the DGC.  Dystroglycan is composed of 
2 subunits, α and β, each produced from the same gene.  
The sarcoglycan complex is composed of multiple 
subunits.  Mutations in the genes encoding for α-, β-, γ-, 
and δ-sarcoglycan can lead to cardiomyopathy and 
muscular dystrophy in humans and mice (68). 
 
We will determine if there are changes in the expression of the six subunits of the 
sarcoglycans after mechanical stimulation.  The transmembrane sarcoglycans are 
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associated with the Dystrophin Glycoprotein Complex which is responsible for force 
transfer in muscle and are critical to the stability of the muscle fiber membranes as well 
as the linking of actin to the extracellular matrix.   
 
Cytoskeletal Genes Which Link Sarcolemma-Associated Proteins with Actin and 
Myosin Intracellularly 
 
Desmin, a type III intermediate filament protein, is muscle-specific and is found 
associated with the sarcomeres.  Desmin filaments are mainly located at the periphery of 
Z-disk of striated muscles and at the dense bodies of smooth muscle cells and they have 
been postulated to play a critical role in the maintenance of structural and mechanical 
integrity of the contractile apparatus in muscle tissues (35).  A 52kD protein, desmin 
contains three major domains: an α-helix rod, a variable non α-helix head, and a carboxy-
terminal tail (35).  As with all intermediate filaments, desmin is non-polar when 
assembled.  The rod domain consists of 308 amino acids with parallel α-helical coiled 
dimers and three linkers to disrupt it.  The rod connects to the head domain.  The head 
domain contains 84 amino acids with many arginine, serine, and aromatic residues and is 
important in filament assembly and dimer-dimer interactions (23).  The tail domain is 
responsible for integration of filaments and interaction with proteins and organelles (26).     
  The expression of desmin gene is regulated by a combination of different 
transcription control regions in muscle cells.  The results from mice deficient in desmin 
reveal its fundamental role in cell architecture, force transmission and mitochondrial 
function (31).  Thus, desmin also plays an important role in muscle cell architecture and 
structure since it connects many components of the cytoplasm (45). 
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Vimentin is a type III intermediate filament protein expressed in mesenchymal 
(stem) cells and is a major cytoskeletal component.  In BSMCs it is often used as a 
marker of mesenchymally-derived cells or cells undergoing an epithelial-to-mesenchymal 
transition during both normal development and metastatic progression (26).  Vimentin 
plays a significant role in supporting and anchoring the position of the organelles in the 
cytosol (26).  Vimentin is attached to the nucleus, endoplasmic reticulum, and 
mitochondria, and is important in offering flexibility to the cell (15).  Vimentin provides 
cells with resilience absent from the microtubule or actin filament network, when under 
mechanical stress in vivo (59).  Therefore, in general, it is accepted that vimentin is the 
cytoskeletal component responsible for maintain cell integrity.  Additionally, cells 
without vimentin are extremely delicate when disturbed with a micropunture (66). 
Focal adhesion proteins such as paxillin serve as a point of convergence for 
signals resulting from the stimulation of various classes of growth factor receptor.  When 
integrins interact with the extracellular matrix, they cluster and recruit a wide variety of 
intracellular proteins (1).  Paxillin, along with talin and vinculin, serves as a focal 
adhesion proteome (51).  It localizes intracellular surface sites of cell adhesion to the 
extracellular matrix at areas called focal adhesions while serving as a scaffold/adapter 
protein at the plasma membrane to coordinate interaction between adhesion and growth 
factor-derived signals (12).  This function results in reorganization of the actin 
cytoskeleton at each site.   
Focal adhesions form a structural link between the extracellular matrix and the 
actin cytoskeleton and are crucial in signal transduction as their components propagate 
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signals arising from the activation of integrins following their interaction with 
extracellular proteins, such as fibronectin, collagen, and laminin (13).  Through the 
interactions of its multiple protein-binding modules, many of which are regulated by 
phosphorylation, paxillin serves as a platform for the recruitment of numerous regulatory 
and structural proteins that control cell adhesion, cytoskeletal reorganization, and gene 
expression (12, 13).   
Paxillin is a 68 kDa multi-domain signal transduction adapter in specialized actin-
membrane-extracellular matrix attachment sites in cultured mammalian cells in vivo (39).  
The C-terminal region of paxillin contains four LIM domains that target paxillin to focal 
adhesions through, presumably, direct association with the cytoplasmic tail of β-integrin.  
The N-terminal region of paxillin is rich in protein-protein interaction sites which are 
capable of binding such as tyrosine kinases, such as Src and FAK and other cytoskeletal 
proteins such as vinculin and actopaxin, and regulators of actin organization, such as 
COOL/PIX and PKL/GIT (39).   
Since the cytoskeleton is intimately associated with actin and myosin and the 
sarcolemma, we will determine whether cytoskeletal genes that encode Desmin, 
Vimentin, and Paxillin proteins are also mechanically regulated by mechanical 
stimulation.  Desmin, a type III intermediate filament specific to muscle cells, is a critical 
linker protein.  Vimentin, another type III intermediate filament, functions to anchor the 
organelles of the cell and offer flexibility during periods of stress of mechanical forces in 
vivo.  It is believed that vimentin is the cytoskeletal component responsible for 
maintaining cell integrity.  Paxillin is a focal adhesion protein which localizes to 
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intracellular sarcolemma sites of physical linkage between cytoskeletal proteins and the 
extracellular matrix at areas called focal adhesions. (12).   
Our rationale for studying expression of the above genes is that their altered 
expression would be able to functionally affect bladder physiology.  Our hypothesis is 
that altered expression of the genes discussed above is a function of the mechanical 
forces experienced by BSMCs. 
We will test this hypothesis by exposing BSMCs to high strain rate mechanical 
stretch and quantify changes in gene expression.  Cells will be plated and stretched using 
a TensorCell machine developed by E.J. Macarak, Ph.D., which permits the application 
of an equibiaxial strain to cultured cells.  Total RNA from stretched cells will be 
extracted and reverse transcribed to obtain complementary DNA (cDNA).  We will 
perform Real-Time PCR on the cDNA sample to quantify relative levels of the mRNAs 
encoding the genes discussed above whose levels will be compared with identical non-
stretched (control) cells.  We anticipate certain genes will respond to high strain rate.   
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2.0 DETAILED METHODS: 
2.1 TensorCell Strain: 
E. J. Macarak, Ph.D. has designed and fabricated a device to impart well-
characterized mechanical forces to BSMCs in vitro.  The device is based upon a positive 
displacement design in which a circular plate (indenter) comes into contact with a 




Figure 2: TensorCell culture cylinders.  TensorCell culture cylinders.  The upper plate 
contains “adapters” which accept the circular culture cylinders whose lower surfaces are 
the distensible membranes.  Culture chambers Culture chambers lock into the adapters 
and are covered with a threaded cap.  The distensible membranes are made of a 
transparent silastic material and are coated with rat tail tendon collagen (RTT).  The 
membranes are stretched across the bottoms of the cylinders and are held in place via an 
elastic O-ring.  Circular indenters attached to the movable plate engage the silicone 
membranes stretching them equibiaxially. 
 
Deformation of a material or a cell that can be related to stresses (forces) is 
described as strain.  As it relates to this study, cell strain can be simplistically defined as a 
change in a linear measurement on the surface of the cell.  For example, fluorescent 
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beads can be attached to a cell surface and their displacement from one another 
measured.  The change in linear distance between the beads after application of a 
deforming force can be measured as the “stretch ratio” ΔL/L, where ΔL represents the 
distance between two points after force application and L represents the original length 
distance prior to force.  In this study, we utilized 10% strain. 
Strain rate is the rate at which the strain is applied to the cell or, simplistically, the 
rate at which the line segment between two points is stretched.  A strain of 5% can be 
applied either over the course of 1 second or 0.1 second.  In the latter example, the strain 
rate is 10X faster.  Deformation can occur in any direction, depending on the way the 
force or stress is applied.  Equibiaxial strain describes the stretching of the cell uniformly 
in all directions simultaneously; as opposed to non-equibiaxial strains, e.g., uniaxial 
strains.  By placing a pattern of labeled dots on a distensible membrane, the relative 
position of the dots can be determined both before and after stretch is applied to the 
membrane.  Selecting a trio of dots and measuring the distances between the three before 
and after stretch, the distances can be used to calculate the changes in length of the two 
principal orthogonal vectors.  We have demonstrated that the magnitude of these two 
vectors is equivalent, meaning the strain is equibiaxial (37).       
Small cylinders, across the bottom of which a distensible membrane is attached, 
serve as culture cylinder.   Cells are plated onto the membrane and allowed to attach 
overnight.  Once the cells have attached to the membrane, the cylinder is placed in the 
upper fixed plate of the apparatus and the top is screwed on, locking it in place.  The 
whole apparatus is moved into a conventional incubator and incubated at 37°C in a 
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humidified atmosphere of 5% CO2 in air.  Cables from the encoder enter through a port at 
the front of the incubator and connect to the motor.  Once the apparatus is positioned in 
the incubator, all strain parameters can be controlled externally via a portable computer.   
A middle plate which is movable and which has indenter rings attached to it is 
located immediately beneath the fixed upper plate.  When the indenter rings contact the 
underside of the elastic membranes that serve as the bottoms of the culture cylinders, the 
membranes are stretched causing them to expand equibiaxially as the indenter rings 
moves upward.  The degree of expansion is linearly related to the vertical travel of the 
indenter and cells attached to the membrane experience a precise equibiaxial strain which 
is both quantifiable and reproducible. 
The movement of the middle plate is via a geared “slide” whose motion is 
controlled by a servo motor.  The rotation of the servo motor shaft is translated into a 
vertical movement of the middle plate by the geared slide and is controlled by software 
instructions that are downloaded into an encoder device that is hardwired to the motor to 
control the shaft’s rotation.  The pitch on the threads (50/1000 inch/revolution) is known, 
so the vertical movement of the indenter per revolution can be calculated and 
programmed to control the movement of the middle plate to induce the desired strain.    
 
2.2 Membrane-Matrix Engineering: 
Membranes are treated with 2-3 ml of 50 μg/ml Rat-Tail Tendon (RTT) collagen 
in 0.5M HAC.  The collagen is permitted to dry on the membranes overnight and yields a 
hydrophilic membrane to which the BSMCs can adhere.  
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2.3 Acquisition and Growth of Bladder Smooth Muscle Cells: 
Human bladder smooth muscle cells were derived from pieces of human bladder 
tissue normally discarded after ureteral re-implant surgery.  Cells were grown in 75 ml
2
 
cell culture flasks in M231 medium (+ Earle’s Salts, L-Glutamine, and 2.2 g/L Sodium 
Bicarbonate) containing 10% fetal calf serum, 25 ml of Smooth Muscle Differentiation 
Supplement (SMDS) and supplemented with antifungal additives of 0.25 ug/ml 
amphotericin B and antibacterial reagents of 100 units/ml BioWhittaker 
Penicillin/Streptomycin incubated in a humidified atmosphere of 5% CO2 in air at 37°C.  
SMDS is an ionically-based supplement containing fetal bovine serum and heparin.  The 
addition of SMDS induces differentiation of normal smooth muscle cells.     
 
2.4 Protocol for Subcultivation of Human Bladder Smooth Muscle Cells: 
1. When cultures became confluent (~105 cells/cm2), cells were subcultured and 
placed into two separate flasks to allow for continued growth and reproduction.   
2. The 75 ml2 cell culture flasks were placed in a laminar flood safety cabinet for all 
re-feeding and subcultivation procedures.   
3. After removal of medium by suction, 10 ml of 0.05% Trypsin-EDTA is added to 
the flask and it is placed in the incubator at 5% CO2 in air at 37°C for 
approximately 7 minutes.  The Trypsin is a serine protease that cleaves cell-
associated attachment proteins releasing them from the culture vessel.    
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4. When cells have detached from the culture flasks as observed under light 
microscopy (~7 minutes), the contents of the flask are suctioned off and placed 
into a 15 ml centrifuge tube.   
5. The cells are centrifuged for 7 minutes at 1200-1400 rpm to obtain a soft pellet of 
BSMCs.   
6. The supernatant of Trypsin-EDTA is gently removed from the test tube and the 
cells are resuspended in 10 ml of M231 medium (+ Earle’s Salts, L-Glutamine, 
and 2.2g/L Sodium Bicarbonate).   
7. 5 ml of the resuspended BSMCs are placed into each of two 75ml2 cell culture 
flasks and an additional 10 ml of M231 medium is added to each.   
8. Both flasks are labeled and returned to the incubator at 5% CO2 in air at 37°C until 
confluent.  
 
2.5 Protein Localization/ Identification: 
Human bladder smooth muscle cells were cultured and plated in separate collagen-coated 
plates at 5% CO2 in air at 37°C.  Cells were grown for 2-4 days or until confluent.  
1. When cells were confluent, medium is suctioned out of wells and cells washed 
with cold PBS 3x.   
2. After the final PBS rinse, cells were fixed with 4% Formaldehyde.   
3. After 15 minutes fixation at room temperature, cells were washed with cold PBS 
3x before adding 0.1% Triton solution to the cells.   
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4. After 15 minutes in room temperature, cells were washed with cold PBS 3x 
before adding 30 µl of the selected primary mouse antibody to the experimental 
slides.  The antibodies used in our experiment were specific for Sarcoglycans (α, 
β, γ, δ and ε; 1:50) Vimentin (1:300 dilution in PBS), Desmin (1:50 dilution in 
PBS), and type IV collagen (1:50 dilution in PBS).   
5. Cells were covered and incubated at 4°C for 1-2 days.   
6. After incubation with primary antibody, cells were washed with cold PBS 3x.  
7. 30 µl of the fluorescent-labeled secondary antibody was added to the slides.   
8. Cells were incubated at room temperature for 1-2 hours.  
9. Cells were washed with cold PBS 3x and coverslipped and sealed with a clear nail 
polish.   
10. Slides were examined with a Zeiss microscope equipped with epifluorescence 
optics and a digital camera.   
11. For controls, primary antibodies were omitted.  
 
2.6 Human Bladder Smooth Muscle Plating to TensorCell Wells: 
TensorCell wells were washed in detergent in a SONOGEN Ultrasound bath before 
being rinsed thoroughly in deionized water and sterilized in 70% ethanol for 24 hours.  
Wells were removed from the ethanol and dried overnight on a sterile surface in the 
laminar flow hood.  Membranes were then coated with RTT collagen as described above.  
1. Confluent cultures of cells growing in T-75 flasks were trypsinized and counted in 
NucleoCounter to obtain cell count per ml.   
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2. After centrifugation and re-suspension of the cell pellet, an equal number of cells, 
based upon the NucleoCounter data were added to each well.  Cells plated at 
confluent density.     
3. The wells were placed in covered petri dishes, and placed petri dishes in sealed 
plastic bags to prevent contamination and incubated overnight at 37°C in a 
humidified atmosphere of 5.0% CO2 in air.   
 
2.7 Application of Strain to Human Bladder Smooth Muscle Cells: 
1. Confluent wells were placed on the apparatus and the program downloaded.  
2. Cells were stretched at 10% strain (20 cycles/min) for 7-8 hours in TensorCell 
machine while incubated at 37°C in a humidified atmosphere of 5.0% CO2 in air.   
3. Control cells remain unstretched and incubated under identical conditions.  
 
2.8 Purification of Total RNA from Human Bladder Smooth Muscle Cells: 
After stretching, wells were removed and washed with clod PBS 3x.  1 ml of 0.05% 
Trypsin-EDTA was added to each well and it was placed in the incubator at 5% CO2 in 
air at 37°C.  After cells have detached from the silicone membrane, 1 ml of M231 
medium was added to neutralize the trypsin/EDTA and the cells were collected by 
centrifugation for 7 minutes at 1200-1400 rpm in sterile tubes and counted using the 
NucleoCounter to obtain an accurate cell count per ml. 
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1. The supernatant was removed from the test tubes and Buffer RLT/ β –ME (see 
Table 1) was added.  Cells were immediately disrupted and homogenized.  
Disrupted cells were pipetted into QIAGEN QIA Shredder Mini Spin Columns.     
 
Table 1: Volumes of Buffer RLT to Tissue Disruption and Homogenization 
Amount of starting material (mg) Volume of Buffer RLT (µl) 
<20 350 or 600* 
20-30 600 
*Use 600 µl Buffer RLT for tissue stabilized in RNAlater RNA Stabilizing or for difficult-to-lyse tissues.   
 
2. The lysates were centrifuged for 2 min at 14000 rpm.  The filter was removed 
from the spin column and 1 volume of 70% ethanol was added to the cleared 
lysate, and mixed immediately by pipetting.   
3. Samples were transferred into a QIAGEN RNeasy Mini Spin Colum and placed in 
a 2 ml collection tube and centrifuged for 15s at 14000 rpm.  The flow-through 
was discarded.  
4. 700 µl Buffer RW1 was added to the RNeasy Spin Column and centrifuge for 15 
s at 14000 rpm to wash the Spin Column membrane after which the flow-through 
was discarded.  
5. The column membrane was washed 3x with 500 µl of Buffer RPE followed by 
centrifugation for 15 s at 14000 rpm.  
6. The RNeasy Spin Column was placed in a new 1.5 ml collection tube and 30-50 
µl RNase-free water added directly to the Spin Column membrane.  The samples 
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were allowed to sit at room temperature for 5 mins followed by centrifugation for 
1 min at 14000 rpm to elute the RNA from the membrane. 
7. The total RNA was quantified by Optical Density (OD) measurements and its 
quality was assessed by 2% agarose gel electrophoresis as seen in Figure 3.    
                                                
Figure 3: The 28S and 18S rRNA subunits in the control 
and experimental samples show that the extracted RNA 
was intact.  
 
 
8. Collected RNA was stored at -80°C.  
2.9 Reverse Transcription (RT) of total RNA from Human Bladder Smooth Muscle 
Cells 
 to Compliment DNA (cDNA):  
 
 Reverse transcription of RNA-to-cDNA was accomplished via a High Capacity 
RNA-to-cDNA kit purchased from Applied Biosystems.  Components of this kit 
(4387406) include 500 µl of 2X RT Buffer Mix and 50 µl of 20X RT Enzyme Mix.      
1. Kit components were allowed to thaw on ice.  
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2. The volume of reagents needed was calculated as shown below in Table 2.  Some 
additional reactions were included in the calculations to provide excess volume 
for the loss that occurs during reagent transfer.  
Table 2: Volumes of kit components used for each experiment. 
Component Volume/Reaction (µl) 
2X RT Buffer 10 
20X RT Enzyme Mix 1 
Nuclease-free H2O *Q.S. to 20 µl 
Sample up to 9 µl 
Total per Reaction 20 
*Q.S. Quantity Sufficient 
3. Reagents were gently mixed and placed on ice.  
4. The thermal cycler was programmed according to the manufacturer’s instructions 
as shown below in Table 3.   
Table 3: These conditions are optimized for use 
with the High Capacity RNA-to-cDNA Kit. 
 
Step 1 Step 2 Step 3 
Temperature 37 95 4 
Time 60 min 5 min  ∞ 
 
 
5. Set the reaction volume to 20 µl.  
6. Load the reactions into the thermal cycler and start the reaction.  
 
2.10 Quantitative Real-Time Polymerase Chain Reaction (PCR) of cDNA: 
 RT-PCR analysis was performed using the Applied Biosystems 7300 PCR 
machine in conjunction with Sequence Detection Software (SDS) v3.1.  Samples were 
loaded into a TaqMan 96-well plate containing a custom format (PN 4413261) of primer 
signatures for 14 experimental genes along with 2 control reagents.  The TaqMan Gene 
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Expression Assays evaluate the yield of cDNA conversion through quantitative PCR 
analysis.  Each of the plates, shown in Figure 4, contains six replicates of manufacturing 
control (18S rRNA) and 15 gene expression primer sets corresponding to the following 
genes: HPRT (control), type III collagen (COL3A1), connective tissue growth factor 
(CTGF), desmin (DES), vimentin (VIM), paxillin (PXN), β-1 integrins (ITGB1), matrix 
metalloprotease-1 (MMP1), tissue inhibitor of MMP1 (TIMP1), α-, β-, γ-, δ-, ε-, and z-
sarcoglycans (SGCA, SGCB, SGCD, SGCG, SGCE, SGCZ).      
 
Figure 4: TaqMan 96-well custom plates containing six 
replicates of manufacturing control (MC) and 15 
experimental assays.  
   
Plates were loaded as described below.  
1. 500 µl of Nuclease-free H2O, 495 µl of TaqMan Master Mix, and 5 µl of RT 
reaction mix was combined into a 1.5 ml sterile sample test tube. 
2. After mixing gently and thoroughly, 20 µl of reaction mix was aliquotted into 
each well of 96-well plate before plate was sealed.  
3. Plate was briefly centrifuged to spin down the contents and to eliminate air 
bubbles. 
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4. The thermal cycling conditions for the plate were specified based on the 
manufacturer’s instructions.   
5. The specific detectors were loaded into the SDS software and the appropriate 
genes were labeled as endogenous controls.   
6. When finished, data was observed and analyzed before exporting to an excel 
spreadsheet.  
7. Once exported, the relative fold change of each gene compared to its respective 
control was analyzed.  
 
For the purpose of comparison between samples, an average of every control is taken 
as a calibrator.  Comparisons of the gene of interest mRNA levels between experimental 
treatments are performed by ΔΔCt analysis according to the following formulas:   
 
Ct(gene of interest) – Ct(housekeeping gene) = ΔCt 
 




Assuming 100% efficiency, each cycle in an RT-PCR represents a doubling of 
double-stranded DNA (dsDNA).  From this assumption, the fold-change in expression for 
each gene of interest’s mRNA level versus the calibrator gene of interest’s mRNA level 
was determined according to the following formula:  
Fold Change(gene of interest) = 2^(- ΔΔCt)(gene of interest)   
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3.0 EXPERIMENTAL EVALUATION:  




 Control BSMCs were first cultured and plated in separate collagen-coated plates.  
Fluorescent-labeled antibodies were used to localize and identify several functional 
distinct proteins of study associated with the force transfer within the cell.  
Immunohistochemistry analysis, seen in Figures 5, 6, 7, and 8, demonstrate the presence 
of these proteins in our control cells.   
 
 
Figure 5: The immunofluorescent analysis of type [III] 
collagen (B; green) and β–sarcoglycans (A; red) demonstrate 
their co-localized positions in the cell. 
 
 
Figure 6: Immunohistochemistry characterizing the 
presence of (clockwise) α-sarc, β-sarc, γ-sarc, and δ-
sarc in the human bladder smooth muscle cells. 
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Figure 7: Immunofluorescent staining displays the 
location of desmin filaments in bladder cells.  Desmin 
filaments form around the dense bodies of smooth 
muscle cells and play a critical role in the maintenance 
of structural and mechanical integrity of the contractile 
apparatus in muscle tissue. 
 
 
Figure 8: Immunohistochemistry used to determine 
the existence of vimentin in BSMCs.  Vimentin 
filaments play a critical role in the positioning and 
stabilization of the muscle cell during contraction and 




3.2 Quantitative RT-PCR Analysis: 
Analysis was carried out on 23 samples of stretched cells and 5 samples of 
unstretched cells.  The average concentration of RNA among the stretched samples was 
127.7 ng/µl, with a range of 4.8 ng/µl to 343.5 ng/µl.  From these samples we reverse 
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transcribed the four with the highest relative concentration of RNA, between 250-350 









Figure 9: Four samples were selected for RT-PCR 
analysis based on their concentration of RNA. 
 
 After RT-PCR was performed and analyzed, the relative fold change of each gene 
was compared to its control.  Fold change is a metric for comparing a gene’s mRNA 
expression level between two distinct conditions.  The fold change of all four samples 
was imported into a spreadsheet and analyzed using a paired t-test to determine the 
statistical significance of each.  Graphical representations of the results are shown below 
in figures 10-23.  All comparisons are between the levels of gene expression of stretched 
cells versus unstretched controls.  Extracellular matrix genes type III collagen 
(COL3A1), connective tissue growth factor (CTGF) and matrix receptor β-integrin all 
showed increased expression.  Matrix metalloprotease-1 (MMP-1) gene expression 
decreased as did its specific inhibitor TIMP-1.  Cytoskeletal genes paxillin (PXN) and 

































vimentin (VIM), increased its expression as a function of stretch.  Within the sarcoglycan 
group, α, β, δ and ζ increased in expression while γ decreased and ε showed no change.     
 *represents statistical significance (p < 0.05) 










Figure 10: Quantitative PCR Analysis Figure 11: Quantitative PCR Analysis   
of α-1 [III] Collagen    of Connective Tissue Growth Factor  
 
 
 Type III collagen and CTGF showed significant up-regulation of gene expression 
in the stretched sample (p= 0.0046 and 0.0269, respectively) when compared to their 







Figure 12: Quantitative PCR Analysis  Figure 13: Quantitative PCR Analysis 
of Integrin β-1     of Paxillin 
 
 
 Integrin β-1 gene expression was up-regulated to a statistically significant level 
after stretch application (p= 0.0305), but cytoskeletal protein paxillin did not show any 








Figure 14: Quantitative PCR Analysis Figure 15: Quantitative PCR Analysis 
of Desmin     of Vimentin 
 
 
 Cytoskeletal protein desmin gene expression did not rise to a statistically 
significant level after the application of stretch (p= 0.0605), but vimentin showed a 






Figure 16: Quantitative PCR Analysis Figure 17: Quantitative PCR Analysis 
of Matrix Metalloprotease-1   Tissue Inhibitor of Metalloprotease-1 
 
 
 Matrix-associated genes MMP-1 and TIMP-1 showed a significant change in 
expression after stretch.  MMP-1 gene expression was effectively eliminated (p= 0.0001) 







Figure 18: Quantitative PCR Analysis Figure 19: Quantitative PCR Analysis 
of α-sarcoglycans    of β-sarcoglycans 
 
 α-, and β-sarcoglycan gene expression increased to a statistically significant level 





Figure 20: Quantitative PCR Analysis  Figure 21: Quantitative PCR Analysis 
of δ-sarcoglycans    of ε-sarcoglycans 
 
 
 δ- sarcoglycan gene expression up-regulated significantly after stretch (p= 
0.0053), but ε-sarcoglycan failed to show any significant alteration as a result of the 







Figure 22: Quantitative PCR Analysis Figure 23: Quantitative PCR Analysis 
of γ-sarcoglycans    of ζ-sarcoglycans 
 
  
 γ-sarcoglycan gene expression was down-regulated significantly after stretch (p= 
0.0002), in contrast to all other transmembrane sarcoglycan proteins while ζ-sarcoglycan 
up-regulated significantly (p= 0.0100).   
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3.3 Discussion: 
It is known that the bladder wall undergoes profound remodeling resulting from 
pathologies such as spinal cord injury or obstruction, but there have been few studies 
examining the role of strain in the remodeling process (46, 50, 53).  This research has 
attempted to study the effect of strain on human bladder smooth muscle cell gene 
expression in vitro, and has shown that strain is capable of inducing profound changes in 
a group of genes chosen for study because of their involvement in the transfer of force 
from within the muscle cell to the extracellular matrix.  Type III collagen was chosen 
because it is a major structural protein found in association with the bladder smooth 
muscle cell in vivo.  CTGF gene expression is involved with the control of matrix gene 
expression for genes like type III collagen, while MMPs and TIMPs exert control over 
matrix degradation.  Vimentin, paxillin and desmin are all cytoskeletal proteins which 
have been implicated in transfer of actin-myosin-generated force in muscle cells to the 
extracellular matrix.  The sarcoglycans are important transmembrane components of the 
DGC and represent physical linkages between cytoskeletal components and the 
extracellular matrix.  Finally, β-integrin is an important matrix receptor which has been 
implicated in cell attachment and adhesion and, therefore, could theoretically be 
implicated in force transfer together with the sarcoglycans.      
The strain parameters chosen mimic some of the physical conditions experienced 
by patients with uncontrolled and non-voiding contractions of the bladder wall.  These 
types of contractions occur at high strain rate and occur in a variety of pathologies 
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including those which result as a consequence of normal aging.  Our data support the 
view that high strain rate forces can alter gene expression in BSMCs.   
In fibrotic tissues, collagen gene expression is altered.  In previous studies of 
patients with either neurogenic or obstructive uropathies, the concentration of type III 
collagen increased from 25% to 33% in bladders with progressive fibrotic changes (1).   
Our data shows that type III collagen gene expression is up-regulated as a consequence of 
the application of 10% strain on BSMCs for 7 hours.  Previous experiments support the 
concept that abnormal cycling can result in progressive fibrosis of the bladder (50).  This 
fibrosis is characterized by infiltration of some detrusor muscle bundles with increased 
quantities of type III collagen.  In the study presented here, we have attempted to mimic 
the conditions found in humans whose bladders sustain uncontrolled, intermittent, non-
voiding contractions.  These types of contractions can be classified as high strain 
contractions since they occur at high frequency over a short period of time.  Normal 
bladder muscle tissue contracts maximally only during voiding, approximately 6 times 
per day.  In our experiments, we have used a strain level of 10% and frequency of 
20/minute to mimic high strain rate contractions.  As a consequence of the force 
parameters used in these studies, major changes in gene expression occurred suggesting 
that mechanical strain plays a major role in regulating a number of genes encoding 
proteins involved in extracellular matrix homeostasis and force transfer within bladder 
smooth muscle cells.  
CTGF plays a critical role in pathogenesis by promoting collagen synthesis and 
deposition.  Similarly, CTGF appears to be regulated by mechanical force and likely 
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contributes to the fibrotic process found in tissues through its regulation by TGF-β.  In 
this study, we found the concentration of CTGF mRNA to be significantly increased after 
exposure to mechanical force.  CTGF, like collagen type III, appears to play a critical role 
in maintaining the steady-state level of matrix macromolecules.  CTGF expression can be 
regulated by TGF-β (36).  It is possible that TGF-β can manifest changes to the 
extracellular environment through its direct or indirect activation of type III collagen and 
CTGF. 
TGF-β is a multifunctional cytokine that has been shown to induce new matrix 
synthesis. Intracellular signaling mediated by TGF-β has been shown to up-regulate 
collagen synthesis by mechanical stretch in other cell types, including smooth muscle 
cells (20, 25).  In addition, neutralizing the TGF-β activity with anti- TGF-β antibody 
ablated stretch-induced up-regulation of collagen mRNA expression (36).  Although we 
did not specifically evaluate changes in TGF- β, previous result are consistent with the 
view that TGF-β up-regulation by mechanical stretch stimulates gene expression of type 
III collagen and that up-regulation is mediated by CTGF.     
Matrix metalloproteases play a critical role in the remodeling of extracellular 
matrix.  Our findings suggest that mechanical strain does not induce MMP-1 synthesis, 
but rather suppresses it.  This data supports the view that mechanical deformation can 
dramatically affect the expression of genes encoding an enzyme that plays an important 
role in the architecture and organization of the extracellular matrix.  One of the 
physiological characteristics of many types of bladder uropathies is increased deposition 
of collagen resulting in decreased bladder compliance.  If there is decreased degradation 
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and increased synthesis of collagen in the bladder wall, the result will be an overall 
increase in the level of collagen in the bladder wall.  This would appear to be the case 
when the cells are subjected to an increased mechanical force.  Overall, the data 
presented here show that there is an increase in gene expression of type III collagen and a 
decrease in expression of MMP which theoretically would result in an overall increase in 
type III collagen.    
The enzymatic activity of MMPs is regulated at several levels, specifically by 
their endogenous inhibitors, TIMPs.  TIMP-1 is a low, tight-binding inhibitor of MMP-1 
collagenase.  Thus, it is logical that the expression of MMPs and TIMPs should be 
inversely proportional.  Our results show that as levels of MMP-1 decrease, TIMP-1 
concentrations fall suggesting that TIMP expression mimics that of MMP expression.   
This would suggest that it is disadvantageous to the cell to produce more TIMP-1 
than is necessarily required at any time.  As an irreversible inhibitor, TIMP-1’s inhibition 
of MMP-1 occurs on a 1:1 scale.  Thus, a cell would only require enough TIMP-1 to 
mitigate the enzymatic activity of MMP-1 and its levels should approximate those of the 
MMP whose activity it inhibits.  Our data shows that MMP-1 activity if effectively 
eliminated in response to the forces applied during our experiments and that a similar 
change in TIMP expression also occurs perhaps via a negative-feedback system.     
 Integrins bind specific amino acid sequences found in extracellular matrix 
proteins.   By virtue of its direct physical attachments to the matrix, cell surface integrins 
are able to respond to environmental forces thus making it a potential 
mechanotransducer.  Our studies demonstrate that after a period of applied strain, the 
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bladder cells significantly up-regulated their transcription of integrin mRNA to a 
statistically significant level.  Integrins may act, in muscle tissue, as an extra mechanism 
for force transfer both inside-to-outside and outside-to-inside.  Integrin-based cell matrix 
binding may strengthen or reinforce other types of force transfer mechanisms such as 
those associated with the DGC.  Increases in integrin expression occur rapidly and may 
be crucial to protect the cell from over stretching the DGC.  Our laboratory has 
previously demonstrated an increase in adherens-based junctions in bladder smooth 
muscle from obstructed animals suggesting that these types of structures may help 
compensate for the increased force demands placed on the DGC which have been 
suggested to be less robust physically than integrin-based binding (68).  Further studies of 
mechanical strain in which the time frame of applied force is varied could be used to 
determine if the cell increases its relative level of integrin receptor proportional to the 
levels of force applied.       
 The gene expression of several cytoskeletal proteins was also quantified.  Paxillin 
serves as a scaffold/adapter protein at the plasma membrane.  Through the interactions of 
its multiple protein-binding modules paxillin serves as a platform for the recruitment of 
numerous regulatory and structural proteins that control cell adhesion, cytoskeletal 
reorganization, and gene expression (12, 13).  Although paxillin is an important 
cytoskeletal protein, it does is not appear to play a significant role in the response of 
BSMCs to force since there was no significant change in paxillin concentration.  The 
same is true of muscle-specific intermediate filament protein desmin whose expression 
was also unchanged.  This would suggest that the steady-state level of desmin mRNA is 
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sufficient to maintain the cells level of this protein, even during periods of increased 
force demands on the smooth muscle cell.   
 Vimentin is the only cytoskeletal protein studied whose expression increases 
significantly.  Prior studies support the view that vimentin is especially critical in 
anchoring organelles to the cytoskeleton and offering flexibility to the cell during periods 
of mechanical stress forces and, thus, it’s up-regulation may be involved with the overall 
process of how a cell responds structurally to an active physical environment in vivo (15, 
66).   
   All sarcoglycan complex component mRNAs except ε showed altered gene 
expression.  With the exception of γ, all sarcoglycans showed increased expression.  This 
supports the view that the sarcoglycan transmembrane proteins function to stabilize the 
sarcolemma during periods of stress and/or normal transfer of intracellularly generated 
force to the extracellular matrix.  The sarcoglycan transmembrane complex functions in 
connecting the muscle fiber cytoskeleton to the extracellular matrix effectively 
transferring actin-myosin induced force across the sarcolemma preventing damage to the 
fiber (54).  Thus, the sarcoglycans are critical components which help the cell 
communicate with and monitor levels of force generated during normal cell activity.  
Their up-regulation is consistent with the view that a cell that is challenged mechanically 
must physically up-regulate those structures required to carry out force transfer.  The γ-
sarcoglycan subunit (SGCG) concentration decreased considerably after the cells were 
subjected to high strain rate.  This statistically significant decrease in concentration is in 
contrast to the results seen among all other sarcoglycan subunits except ε which showed 
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no change.  One possible explanation for this can be derived from research performed by 
Tewari, et al. (62).  Their studies, involving skeletal muscle cells, found evidence to 
support the view that δ-sarcoglycan function is associated with cell rigidity.  Mice 
deficient in SGCG exhibited an increased contractile response that resulted in greater 
shortening and widening of the sarcolemma.  The researchers concluded that SGCG 
normally moderates contractile stress in skeletal muscle.  It is possible that SGCG plays a 
similar role in smooth muscle and the drastic decrease in concentration is a natural 
response to mechanical forces to permit the sarcoglycan complex to be more flexible.   
 Taken together, these results suggest that BSMCs respond to stretch by up-
regulating a number of genes responsible for force transfer across the sarcolemma 
including the sarcoglycans, β-integrin and the cytoskeletal protein vimentin.  In addition, 
there is a very significant and substantial up-regulation of type III collagen and CTGF 
whose combined activities can lead to a major change in the composition of the 







1. Bakolista, C., de Pereda, J.M., Bagshaw, C.R., Critchley, D.R., Liddington, R.C.:  Crystal 
structure of the vinculin tail suggests a pathway for activiation. Cell Biology, 99; 603-619, 1999.  
2. Baskin, L.S., Howard, P.S., Macarak, E.J.:  Effect of physical forces on bladder smooth muscle 
and urothelium.  Journal of Urology, 150; 601-607, 1993.   
3. Baskin, L., Howard, P.S. and Macarak, E.J.:  Effect of mechanical forces on extracellular matrix 
synthesis by bovine urethral fibroblasts in vitro. Journal of Urology, 150: 637-641, 1993.  
4. Baskin, L.S, Macarak, E.J., Duckett, J.W., Snyder, H.S. and Howard, P.S.: Culture of urethral 
fibroblasts: cell morphology, proliferation and extracellular matrix synthesis.  Unpublished data.  
5. Bissel, M. and M. Barcellos-Hoff.:  The influence of extracellular matrix on gene expression.  
Journal of Cellular Science., 8; 327-343, 1987.  
6. Bord, S., Horner, A., Beeton, C.A., Hembry, R.M., Compston, J.E.:  Tissue inhibitor of matrix 
metalloproteinase-1 (TIMP-1) distribution in normal and pathologic human bone. Bone, 13; 93-
98, 1999.  
7. Bornstein, P. and Sage, H.: Regulation of collagen gene expression.  Progress in Nucleic Acid 
Research and Molecular Biology, 37: 67, 1989. 
8. Bradley, W.E., Long, D.M.:  Morphology of the developing bladder. Invest Urol, 7; 66-71, 1969.  
9. Brown, T.D.: Techniques for mechanical stimulation of cells in vitro: a review.  Journal of 
Biomechanical Engineering, 33; 3-14, 2000  
10. Brown, T.D.:  Mechanical stimulation of cells in vitro. Journal of Biomechanical Engineering, 33; 
3-14, 2000.  
11. Burgeson, R.E. and Nimni, M.E.: Collagen types.  Molecular structure and tissue distribution.  
Clinical Orthopaedics & Related Research, 282: 250, 1992.  
12. Burridge, K., Fath, K., Kelly, T., Nuckolls, G., and Turner, C.:  Focal adhesions: transmembrane 
junctions between the extracellular matrix and the cytoskeleton.  Annu Rev. Cell Biol., 4; 487-
525, 1988.  
13. Burridge, K., Turner, C.E., and Romer, L.H.:  Tyrosine phosphorylation of paxillin and oo125FAK 
accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J. Cell Biol, 
119; 893-903, 1992.  
14. Carano, A., Siciliani, G.:  Effect of continuous and intermittent forces on human bladder in vitro. 
Eur J Orthod, 18; 19-26, 1998.  
15. Chan, W., Kozma, R., Yasui, Y., Inagaki, M., Leung, T., Manser, E., Lim, L.:  Vimentin 
intermediate filament reorganization. Eur Journal of Cell Biology, 81; 692-701, 2002.  
16. Chang, S.L., Howard, P.S., Macarak, E.J.:  Role of type III collagen in bladder filling. Neurourol 
Urodyn, 17; 135-145, 1998.  
17. Chen, K.D., Li, Y.S., Kim, M., Li, S., Yuan, S., Chien, S., and Shyy, J.Y.:  Mechanotransduction 
in respons to shear stress: roles of receptor tyrosine kinases, integrins, and Shc. J. Biol. Chem., 
247; 18393-18400, 1999.  
18. Chen, H., Zou, Z., Sarratt, K.L., Zhou, D., Zhang, M., Sebzda, E., Hammer, D.A., and Kahn, 
M.L.:  In vivo beta-1 integrin function requires phosphorylation-independent regulation by 
cytoplasmic tyrosines. Genes Div, 20; 927-932, 2006.  
19. Chujo, S., Shiraski, F., Kawara, S., Inagaki, Y., Kinbara, T., Inaoki, M., et al.:  Connective tissue 
growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming 
growth factor-beta in a mouse fibrosis model. J. Cell Physiol, 203; 447-456, 2005.  
20. Cicha, I., Goppelt-Struebe, M.:  Connective tissue growth factor: Context-dependent functions and 
mechanisms of regulation. Biofactors, 35; 200-228, 2009.  
21. Clark, I.M., Powell, L.K., Cawston, T.E.:  Tissue inhibitor of matrix metalloproteinase-1 (TIMP-
1) stimulated the secretion of collagenase from human skin fibroblasts. Biochemical and 
Biophysical Research Communications, 203; 874-880, 1994.  
22. Cortivo, R., Pagano, F., Passerini, G., Abatangelo, G., Castellani, I.:  Elastin and Collagen in the 
normal and obstructed  urinary bladder. Journal of Urology, 53; 134, 1991.  
45 
23. Dahl, K.N., Ribeiro, J.S., Lammerding, J.:  Nuclear shape, mechanics, and mechanotransduction. 
Circ. Res., 102; 1307-1318, 2008.  
24. Deveaud, C.M., Macarak, E.J., Kucich, U., Ewalt, D.H., Abrams, W.R. and Howard, P.S.: 
Molecular analysis of collagens in bladder fibrosis.  Journal of Urology, 136; 134, 1998.   
25. De Winter, P., Leoni, P., Abraham, D.: Connective tissue growth factor: structure-function 
relationships of mosaic, multifunctional protein. Growth Factors, 26; 80-91, 2008.  
26. E. Lazaridea, B.L. Granger, D.L. Gard, C.M. O’Connor, J. Breckler, M. Price, S.I. Danto:  
Desmin- and vimentin-containing filaments and their roles in the assembly of the z disk in muscle 
cells. Quant Biol, 46; 351-378, 1982.  
27. Eheil, A., Igondjo-Tchen, S., Ghomrasseni, S., Pellat, B., Godeau, G., Gogly, B.:  Expression of 
matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in healthy 
and diseased human gingival. Journal of Periodontology, 74; 188-195, 2003.  
28. Ewalt, D.H., Constantinescu, S., Howard, P.S., et al.:  Increased collagen type III in the 
neurogenic non-compliant bladder. Journal of Urology, 147; 438A, 1992.  
29. Garcia-Alvarez, B., de Pereda, J.M., Calderwood, D.A., Ulmer, T.S., Crithcley, D., Campbell, 
I.D., Ginsberg, M.H., and Liddington, R.C.:  Structural determinats of integrin recognition by 
talin. Mol. Cell. 11; 49-58, 2003.  
30. Giplin, S.A., Gosling, J.A., Barnard, R.J.:  Morphological and morphometric studies of the human 
obstructed, trabeculated urinary bladder.  Journal of Urology, 57; 525, 1985.   
31. Goldfarb, L.G., Vicart, P., Goebel, H.H., Dalakas, M.C.:  Desmin Myopathy. Journal of Cell 
Biology, 127; 723-734, 2004.  
32. Kim, K.M., Kogan, B.A., Massad, C.A., Huang, Y.C.:  Collagen and elastin in the obstructed fetal 
bladder. Journal of Urology, 146; 528, 1991.  
33. Kirtz, T.Z., Mark, M.E., Chua, C.C., Chua, B.H., Mayes, M.D.:  Myofibroblasts from sarcolemma 
synthesize elevated levels of collagen and tissue inhibitor of metallopreoteinase (TIMP-1). The 
Journal of Biological Chemistry, 270; 3423-3428, 1995.  
34. Kochanek, K.D., Murphy, S.L., Anderson, R.N., Scott, C.:  Deaths: final data for 2002. Natl Vital 
Stat Rep, 53; 1-115, 2002.  
35. Kreplak, L., Herrmann, H., Aebi, U.:  Tensile properties of single desmin intermediate filaments. 
Biophysical Journal, 94:7; 2790-2799, 2008.  
36. Leask, A., Parapuram, S.K., Shi-wen, X., Abraham, D.J.:  Connective tissue growth factor (CTGF, 
CCN2) gene regulation: a potent clinical bio-marker of Fibroproliferative disease?.  J. Cell 
Commun Signal, 3; 89-94, 2009.  
37. Lee, A.A., Tammo, D.,Waldman, L.K., MacKenna, D.A., Villarreal, F.J., McCulloch, A.D.: An 
equibiaxial strain system for cultured cells.  Am. J of Cell Physiol., 271; C1400-C1408, 1996.  
38. Lee, S.J., Talic, N.F., Loreto, C.:  Endostatin binds to the catalytic domain of matrix 
metalloproteinase-1. FEBS Letters, 519; 147-152, 2002.  
39. Lewis, J.M., and Schwartz, M.A.:  Integrins regulate the association and phosphorylation of 
paxillin by c-Abl, Chem, 273; 14225-14230, 1998.  
40. Liau, G. Yamada, Y. and de Crombrugghe, B.:  Coordinate regulation of the levels of type III and 
type I collagen mRNA in most but not all fibroblasts.  J. Biol. Chem., 260; 531, 1985.   
41. Li, G., Xie, Q., Shi, Y., Li, D., Zhang, M., Jiang, S., et al.:  Inhibition of connective tissue growth 
factor by siRNA prevents liver fibrosis in rats. J. Gene Med, 8; 889-900, 2006.  
42. Liddington, R.C., and Ginsberg, M.H.:  Integrin activation takes shape. J. Cell. Biol., 158; 833-
839, 2002.  
43. Liu, M., Xu, J., Souza, P., Tanswell, B., Tanswell, A.K. and Post, M.:  The effect of mechanical 
strain on fetal rat bladder proliferation: comparison of two- and three-dimensional culture 
systems.  in Vitro Cell Dev Biol Anim, 31: 858-866, 1995.  
44. Macarak, E.J.:  Collagen synthesis by cloned pulmonary artery endothelial cells.  Journal of Cell 
Physiology, 119; 175-182, 1984.  
45. Marmol, A.M., Strasser, G., Isamat, M., Coulombe, P.A., Yang, Y., Roca, X., Vela, E., et al.:  A 
dysfunctional desmin mutation in a patient with severe generalized myopathy. PNAs, 95: 19; 
11312-11317, 1998.  
46 
46. Monson, F.C., McKenna, B.A., Wein, A.J., et al.:  Effect of outlet obstruction on biochemical 
processes. Journal of Urology, 34; 1003-1011, 1986.  
47. Nagase, H., Visse, R., Murphy, G.:  Structure and function of matrix metalloproteinases and 
TIMPs. Cardiovascular Research, 69; 562-573, 2006. 
48. Olsen, A.S., and Prockop, D.:  Transcription of human type I collagen genes: variation in the 
relative rates of transcription of the pro a-1 and a-2 genes. Matrix, 9; 73, 1989.  
49. Opazo, S.A., Zhang, W.Y., Turner, C.E., Tang, D.D., Gunst, S.J.:  Tension development during 
contractile stimulation of smooth muscle requires recruitment of paxillin and vinculin to the 
membrane. American Journal Cell Physiology, 286; 433-447, 2004.  
50. Peters, C.A., Vasavada, S., Dator, D., Carr, M., Shapiro, E., Lepor, H., et al.:  The effect of 
obstruction on the developing bladder. Journal of Urology, 148; 491-497, 1992.  
51. Petrof, B.J., Shrager, J.B., Stedman, H.H., Kelly, A.M., Sweeney, H.L.:  Dystrophin protects the 
sarcolemma from stresses developed during muscle contraction. Proc National Acad Sci USA, 90; 
3710-3714, 1993.  
52. Redlich, M., Reichenberg, E., Harari, D., Zaks, B., Shoshan, S., Palmon, A.,:  The effect of 
mechanical force on mRNA levels of collagenase, collagen type I, and tissue inhibitor of 
metalloproteinases in ginginvae of dogs. Journal of Dental Research, 80; 2080-2084, 2001. 
53. Robbins, S.L., Cotran, R.S.: Inflammation and repair.  In: Pathologic basis of disease.  
Philadelphia: W.B. Saunders; 40-84, 1984.  
54. Rybakova, I.N., Patel, J.R., Ervasti, J.M.:  The dystrophin complex forms a mechanically strong 
link between the sarcolemma and costameric actin. Journal of Cell Biology, 150; 1209-1214, 
2000.  
55. Schmidt, C.E., Horwitz, A.F., Lauffenburger, D.A., and Sheetz, M.P.:  Integrin-cytoskeletal 
interactions in migrating fibroblasts are dynamic, asymmetric, and regulated. J. Cell Biol., 123; 
977-991, 1993.  
56. Shi-wen, X., Leask, A., Abraham, D.:  Regulation and function of connective tissue growth 
factor/CCN2 in tissue repair, scarring and fibrosis. Cyotkine Growth Factor Rev, 19; 133-144, 
19.  
57. Sobue, T. et al.:  Tissue inhibitor of metalloproteinase 1 and 2 directly stimulate bone-resorbing 
activity in mature osteoclasts.  Journal of Bone and Mineral Research, 16; 2205-2214, 2001.  
58. Sumpio, B.E., Banes, A.J., Link, W.G. and Johnson, G.J.:  Enhanced collagen production by 
smooth muscle cells during repetitive mechanical stretching.  Arch. Surg., 123: 1233-1236, 1988.  
59. Tang, D.D., Tao, P., Bai, Y.:  Activated protein kinase 1 is required for vimentin phosphorylation 
during stimulation of smooth muscle tissue. FASEB J., 18; 1085, 2004.  
60. Tang, D.D., Turner, C.E., Gunst, S.J.:  Expression of non-phosphorylated paxillin mutants in 
canine tracheal smooth muscle inhibits tension development. J. Physiology, 553; 21-35, 2003.  
61. Thibault, L.E. and Fry, D.:  Mechanical characterization of membranelike biological tissue.  
Journal of Biomechanical Engineering, 105; 31-38, 1983.  
62. Tewari, M., Griffin, M.A., Feng, H., Acosta, P., Kawana, M., Sweeney, H.L, Discher, D.E.:  
Gamma-sarcoglycan deficiency increases cell contractility, apoptosis and MAPK pathway 
activation but does not affect adhesion. J. Cell Sci., 118; 1405-1416, 2005.  
63. Uvelius, B., Lindner, P. and Mattiasson, A.: Collagen content in the rat urinary bladder following 
removal from an experimental infravesical outlet obstruction.  Urol. Int., 47: 245, 1991.   
64. Van der Rest, M. and Garrone, R.: Collagen family of proteins.  FASEB J., 5: 2814, 1991  
65. Verstappen, J., Von den Hoff, J.W.:  Tissue inhibitors of metalloproteinases (TIMPs): their 
biological functions.  Journal of Dental Research, 85; 1074-1084, 2006.  
66. Wang, R., Li, Q., Tang, D.D.:  Role of vimentin in smooth muscle force development. American 
Journal Cell Physiology, 291; 483-489, 2006.  
67. Wein, A.J., Levin, R.M. and Barret, D.M.:  Voiding function, relevant anatomy, physiology, and 
pharmacology.  Adult and Pediatric Urology, 2
nd
 Edition.  Chicago: Year Book Medical 
Publishers, 933-99, 1991.  
47 
68. Zderic, S.A., Macarak, E.J., Shulz, J., Sado, Y., Ninomiya, Y., Polyak, E., Chacko, S., Howard, 
P.S.: Smooth muscle trans-membrane sarcoglycan complex in partial bladder outlet obstruction.  
Histochem Cell Biol, 126; 71-82, 2006 
69. Figure 1 image courtesy of: http://www.humpath.com/?dystrophin-glycoprotein-
complex&id_document=24420.  Accessed in 2/2012.   
 
